Company intelligence
MiMedx
Medical Equipment Manufacturing
Marietta, US
763 employees
Founded 2008
4 public signals
About MiMedx
MIMEDX is a pioneer and leader in the field of placental tissue. With more than a decade of helping clinicians manage chronic and hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical settings of healthcare. The Company's vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life.
Verified activity
Signals from MiMedx
4 published signals
Research & Knowledge
MiMedx published a retrospective, multicenter study in the European Surgical Research Journal evaluating 30-day outcomes in complicated diverticulitis patients receiving AMNIOFIX as a protective barrier after colectomy anastomosis, referencing the ACS-NSQIP national database.
Reported by MiMedx
Products & Services
MiMedx announced that AMNIOFIX is an amnion/chorion placental allograft that may be used as a protective barrier on surgical wounds and exposed tissues to support the healing process.
Reported by MiMedx
Products & Services
MiMedx launched the new Product in Practice module on Wound Care Today USA featuring the science behind RegenKit®-Wound Gel.
Reported by MiMedx
Research & Knowledge
MiMedx published a retrospective, multicenter study comparing outcomes in complicated diverticulitis patients who received AMNIOFIX as a protective barrier after colectomy anastomosis using a contemporary standard-of-care benchmark from the published literature.
Reported by MiMedx